跳至主要内容
临床试验/JPRN-UMIN000010940
JPRN-UMIN000010940已完成未知

The comparison of azilsartan and amlodipine for treatment of VEGF receptor-tyrosine kinase inhibitor-induced hypertension in advanced kidney cancer patients - The comparison of azilsartan and amlodipine for treatment of VEGFR-TKI-induced hypertension

Kanazawa University, 13-1 Takaramachi, Kanazawa0 个研究点目标入组 10 人开始时间: 2013年6月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. < 20 year-old 2. Cr>3.0mg/dl or eGFR<15ml/min 3. bilateral renal arterial stenosis or unilateral renal rterial stenosis in solitary kidney 4. allergy to angiotensin 2 receptor blockers or calcium channel blockers and patients who were thought as inadequate for this study by doctor in charge

研究者

发起方
Kanazawa University, 13-1 Takaramachi, Kanazawa

相似试验

The comparison of azilsartan and amlodipine for... | 临床试验